View in EDS

[Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia].

Saved in:
Bibliographic Details
Title: [Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia].
Authors: Yan ZS; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China., Suo XH; Department of Hematology, Handan Central Hospital, Handan 056000, China., Bai GC; Department of Hematology, the Affiliated Taian City Central Hospital of Qingdao University, Taian 271000, China., Zhang B; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China., He JS; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China., Li JS; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China., Wei SN; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China., Li QL; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China., Liu KQ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China., Mi YC; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.
Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2026 Apr 14; Vol. 47 (4), pp. 379-382.
Publication Type: English Abstract; Journal Article
Journal Info: Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium: Print ISSN: 0253-2727 (Print) Linking ISSN: 02532727 NLM ISO Abbreviation: Zhonghua Xue Ye Xue Za Zhi Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42161662
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: [Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia].
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yan+ZS%22">Yan ZS</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.<br /><searchLink fieldCode="AU" term="%22Suo+XH%22">Suo XH</searchLink>; Department of Hematology, Handan Central Hospital, Handan 056000, China.<br /><searchLink fieldCode="AU" term="%22Bai+GC%22">Bai GC</searchLink>; Department of Hematology, the Affiliated Taian City Central Hospital of Qingdao University, Taian 271000, China.<br /><searchLink fieldCode="AU" term="%22Zhang+B%22">Zhang B</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.<br /><searchLink fieldCode="AU" term="%22He+JS%22">He JS</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.<br /><searchLink fieldCode="AU" term="%22Li+JS%22">Li JS</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.<br /><searchLink fieldCode="AU" term="%22Wei+SN%22">Wei SN</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.<br /><searchLink fieldCode="AU" term="%22Li+QL%22">Li QL</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.<br /><searchLink fieldCode="AU" term="%22Liu+KQ%22">Liu KQ</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.<br /><searchLink fieldCode="AU" term="%22Mi+YC%22">Mi YC</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Medical Health Research Institute, Tianjin 301600, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228212398%22">Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi</searchLink> [Zhonghua Xue Ye Xue Za Zhi] 2026 Apr 14; Vol. 47 (4), pp. 379-382.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: English Abstract; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Chinese+Medical+Association%22">Chinese Medical Association </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>8212398 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0253-2727 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202532727%22">02532727 </searchLink><i>NLM ISO Abbreviation: </i>Zhonghua Xue Ye Xue Za Zhi <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42161662
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3760/cma.j.cn121090-20250516-00232
    Languages:
      – Code: chi
        Text: Chinese
    PhysicalDescription:
      Pagination:
        StartPage: 379
    Titles:
      – TitleFull: [Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia].
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yan ZS
      – PersonEntity:
          Name:
            NameFull: Suo XH
      – PersonEntity:
          Name:
            NameFull: Bai GC
      – PersonEntity:
          Name:
            NameFull: Zhang B
      – PersonEntity:
          Name:
            NameFull: He JS
      – PersonEntity:
          Name:
            NameFull: Li JS
      – PersonEntity:
          Name:
            NameFull: Wei SN
      – PersonEntity:
          Name:
            NameFull: Li QL
      – PersonEntity:
          Name:
            NameFull: Liu KQ
      – PersonEntity:
          Name:
            NameFull: Mi YC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 04
              Text: 2026 Apr 14
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 0253-2727
          Numbering:
            – Type: volume
              Value: 47
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
              Type: main
ResultId 1